Cargando…
281 Use of Monoclonal Antibody Omalizumab in the Treatment of Urticaria Chronic
BACKGROUND: The chronic Urticaria is a real problem of health and a frequent problem in the consultation of the allergist, which the treatment is not to satisfactory. Some Urticaria can be for autoimmunity where the antibody involved is IgE. Omalizumab is an monoclonal antibody against the C3 domain...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
World Allergy Organization Journal
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513150/ http://dx.doi.org/10.1097/01.WOX.0000412038.77501.a8 |